Abstract
Eprosartan mesylate (EM), an angiotensin II antagonist, is used as an antihypertensive drug. Its poor (13%) bioavailability is limited by its solubility rather than metabolism (hepatic CYP450). The hydrogen bond interactions between EM and pharmaceutical coformers involving carboxylic–carboxylic or carboxylic–amino interactions have been considered as the basis for the formation of cocrystals. A liquid-assisted grinding method was successfully employed. These cocrystals were characterized on the basis of their unique thermal (differential scanning calorimetry) and spectroscopic (Fourier transform infrared spectroscopy FTIR) profiles. They were confirmed by powder X-ray diffraction studies and characteristic vibrational modes in Raman spectra. The cocrystals prepared using succinic, p-aminobenzoic, and salicylic acids exhibited markedly high solubility (30–60-fold) compared to that of the pure drug (EM). In vitro dissolution studies also showed impressive dissolution profiles (50%), suggesting that they favor an increase in the oral bioavailability of EM.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
